首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1469860

全球蛋白质工程市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Protein Engineering Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年04月01日 | 出版商:

Value Market Research | 英文 283 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球蛋白质工程市场需求预计将从2023年的20.9亿美元达到2032年近87.4亿美元的市场规模，2024-2032年研究期间复合年增长率为17.23%。

蛋白质工程是一个生物技术领域，专注于针对特定应用设计、修饰和优化蛋白质。它涉及分子建模、合理设计、定向进化和重组 DNA 技术，以创造具有所需特性和功能的蛋白质。它在医学、农业、工业和生物技术领域有多种应用，包括开发治疗性蛋白质、酵素、疫苗、生物感测器和生物材料。透过利用蛋白质结构和功能的原理，蛋白质工程能够设计出具有改进的稳定性、活性、特异性和其他所需特性的新型分子。

市场动态

对治疗各种疾病（包括癌症、自体免疫疾病和传染病）的治疗性蛋白质和生物製药的需求不断增长，推动了对创新蛋白质工程技术的需求，以优化蛋白质功能、稳定性和药物动力学。此外，蛋白质工程技术的进步，例如合理设计、定向进化和计算建模，使得能够开发具有增强功效、特异性和安全性的新型蛋白质疗法。此外，製药公司、学术机构和政府机构对生物技术研发的投资不断增加，正在推动创新并推动蛋白质工程技术的商业化。

此外，蛋白质工程在治疗领域之外的广泛应用，例如用于工业生物催化的酶工程、用于生物材料和药物传输系统的蛋白质设计以及用于农业生物技术的蛋白质优化，正在创造新的市场机会并推动成长。蛋白质工程技术在个人化医疗、诊断和再生医学中的日益采用推动了市场的扩张。此外，公司、生物製药公司和研究机构之间的策略合作和伙伴关係正在促进创新并加速蛋白质产品的开发和商业化。然而，对医疗设备隐私和资料安全的担忧可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球蛋白质工程市场的每个细分市场进行了包容性评估。蛋白质工程行业的成长和趋势为这项研究提供了整体方法。

市场区隔

蛋白质工程市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

仪器
试剂
软体与服务

依技术

合理的蛋白质设计
定向进化
混合方法
从头蛋白质设计
其他的

依蛋白质类型

胰岛素
单株抗体
疫苗
生长因子
集落刺激因子
凝血因子
干扰素
其他的

按最终用途

学术研究机构
合约研究组织（Cros）
製药与生物技术公司

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲蛋白质工程市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。蛋白质工程市场的主要参与者包括安捷伦科技公司、布鲁克公司、赛默飞世尔科技公司、珀金埃尔默公司、沃特世公司、Bio-Rad Laboratories、默克公司、丹纳赫公司、金斯瑞生物科技公司、安进公司本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来能力、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 按产品分類的市场吸引力分析
- 按技术分類的市场吸引力分析
- 按蛋白质类型进行的市场吸引力分析
- 按最终用途分類的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球蛋白质工程市场分析：副产品

概述（按产品）
历史和预测数据
按产品分析
仪器
试剂
软体与服务

第 6 章：全球蛋白质工程市场分析：依技术分类

依技术概述
历史和预测数据
技术分析
合理的蛋白质设计
定向进化
混合方法
从头蛋白质设计
其他的

第 7 章：全球蛋白质工程市场分析：按蛋白质类型

依蛋白质类型概述
历史和预测数据
依蛋白质类型分析
胰岛素
单株抗体
疫苗
生长因子
集落刺激因子
凝血因子
干扰素
其他的

第 8 章：全球蛋白质工程市场分析：依最终用途

按最终用途分类的概述
历史和预测数据
按最终用途分析
学术研究机构
合约研究组织 (CRO)
製药与生物技术公司

第 9 章：全球蛋白质工程市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 10 章：蛋白质工程公司的竞争格局

蛋白质工程市场竞赛
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 11 章：公司简介

顶级公司市占率分析
市场集中度
Agilent Technologies

公司简介
公司收入
产品
最近的发展

Bruker Corp.

公司简介
公司收入
产品
最近的发展

Thermo Fisher Scientific Inc.

公司简介
公司收入
产品
最近的发展

PerkinElmer Inc.

公司简介
公司收入
产品
最近的发展

Waters Corp.

公司简介
公司收入
产品
最近的发展

Bio-Rad Laboratories

公司简介
公司收入
产品
最近的发展

Merck KGaA

公司简介
公司收入
产品
最近的发展

Danaher Corp.

公司简介
公司收入
产品
最近的发展

Genscript Biotech Corp

公司简介
公司收入
产品
最近的发展

Amgen Inc.

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112114269

The global demand for Protein Engineering Market is presumed to reach the market size of nearly USD 8.74 Billion by 2032 from USD 2.09 Billion in 2023 with a CAGR of 17.23% under the study period 2024 - 2032.

Protein engineering is a biotechnology field focused on designing, modifying, and optimizing proteins for specific applications. It involves molecular modeling, rational design, directed evolution, and recombinant DNA technology to create proteins with desired properties and functionalities. It has diverse applications in medicine, agriculture, industry, and biotechnology, including developing therapeutic proteins, enzymes, vaccines, biosensors, and biomaterials. By harnessing the principles of protein structure and function, protein engineering enables the design of novel molecules with improved stability, activity, specificity, and other desired characteristics.

MARKET DYNAMICS

Increasing demand for therapeutic proteins and biopharmaceuticals for treating various diseases, including cancer, autoimmune disorders, and infectious diseases, drives the need for innovative protein engineering technologies to optimize protein function, stability, and pharmacokinetics. Additionally, advancements in protein engineering techniques, such as rational design, directed evolution, and computational modeling, enable the development of novel protein-based therapeutics with enhanced efficacy, specificity, and safety profiles. Furthermore, the growing investment in biotechnology research and development by pharmaceutical companies, academic institutions, and government agencies is fueling innovation and driving the commercialization of protein engineering technologies.

Moreover, the expanding applications of protein engineering beyond therapeutics, such as enzyme engineering for industrial biocatalysis, protein design for biomaterials and drug delivery systems, and protein optimization for agricultural biotechnology, are creating new market opportunities and driving growth. The increasing adoption of protein engineering technologies in personalized medicine, diagnostics, and regenerative medicine drives market expansion. Furthermore, strategic collaborations and partnerships among companies, biopharmaceutical firms, and research institutions are fostering innovation and accelerating the development and commercialization of protein-based products. However, concerns regarding privacy and data security in medical devices may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of protein engineering. The growth and trends of protein engineering industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the protein engineering market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Instruments
Reagents
Software & Services

By Technology

Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
Others

By Protein Type

Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
Others

By End-Use

Academic Research Institutes
Contract Research Organizations (Cros)
Pharmaceutical & Biotechnology Companies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Protein Engineering market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Protein Engineering market include Agilent Technologies, Bruker Corp., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Waters Corp., Bio-Rad Laboratories, Merck KGaA, Danaher Corp., Genscript Biotech Corp, Amgen Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PROTEIN ENGINEERING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Protein Type
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Instruments Historic and Forecast Sales By Regions
5.5. Reagents Historic and Forecast Sales By Regions
5.6. Software & Services Historic and Forecast Sales By Regions

6. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data
6.3. Analysis By Technology
6.4. Rational Protein Design Historic and Forecast Sales By Regions
6.5. Directed Evolution Historic and Forecast Sales By Regions
6.6. Hybrid Approach Historic and Forecast Sales By Regions
6.7. De Novo Protein Design Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY PROTEIN TYPE

7.1. Overview By Protein Type
7.2. Historical and Forecast Data
7.3. Analysis By Protein Type
7.4. Insulin Historic and Forecast Sales By Regions
7.5. Monoclonal Antibodies Historic and Forecast Sales By Regions
7.6. Vaccines Historic and Forecast Sales By Regions
7.7. Growth Factors Historic and Forecast Sales By Regions
7.8. Colony Stimulating Factors Historic and Forecast Sales By Regions
7.9. Coagulation Factors Historic and Forecast Sales By Regions
7.10. Interferon Historic and Forecast Sales By Regions
7.11. Others Historic and Forecast Sales By Regions

8. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY END-USE

8.1. Overview By End-use
8.2. Historical and Forecast Data
8.3. Analysis By End-use
8.4. Academic Research Institutes Historic and Forecast Sales By Regions
8.5. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions
8.6. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions

9. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PROTEIN ENGINEERING COMPANIES

10.1. Protein Engineering Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF PROTEIN ENGINEERING INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Agilent Technologies
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Bruker Corp.
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Thermo Fisher Scientific Inc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. PerkinElmer Inc.
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Waters Corp.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Bio-Rad Laboratories
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Merck KGaA
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Danaher Corp.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Genscript Biotech Corp
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Amgen Inc.
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments